Home
Ichnos Glenmark Innovation

Ichnos Glenmark Innovation Market Share Analysis for July 2026

Our Pipeline is comprised of Biologics, including the proprietary BEAT® MultispecificsTM platform, and Small Molecules targeting...

Industry: N/A

Domainiginnovate.com

Year Founded--

Employees51 - 200

Annual Revenue--

Ichnos Glenmark Innovation

Ichnos Glenmark Innovation (including company regionals)

iginnovate.com

See more website traffic and engagement information

Total visits to Ichnos Glenmark Innovation's top domains

Understand Ichnos Glenmark Innovation market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

iginnovate.com3.1K

See more with Sales Intelligence

Avg. visit duration in Ichnos Glenmark Innovation's top domains

Analyze Ichnos Glenmark Innovation engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

iginnovate.com00:00:37

See more with Sales Intelligence

Avg. pageviews on Ichnos Glenmark Innovation's top domains

See how Ichnos Glenmark Innovation keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

iginnovate.com1.88

See more with Sales Intelligence

Ichnos Glenmark Innovation top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Ichnos Glenmark Innovation

These are the website technologies, by industry, used by Ichnos Glenmark Innovation top domains

Widget (7)

Twemoji

Payment & Currencies (3)

PayPal

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from Ichnos Glenmark Innovation

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIginnovate attends event ISB 2001.Ichnos Glenmark Innovation's ISB 2001 takes US FDA Fast Track designation for multiple myeloma.

NewsIginnovate hired Lida Pacaud as Interim Chief Executive Officer on Dec 4th '25.Ichnos Glenmark Innovation, Inc. (IGI), a global clinical-stage biotechnology company focused on developing multispecifics in oncology, today announced the appointment of Lida Pacaud, M.D., as Interim Chief Executive Officer.

NewsAbbVie partnered with Iginnovate on Jan 1st '01.AbbVie, a biopharmaceutical company focused on immunology and oncology, has entered an exclusive licensing agreement with IGI Therapeutics SA, a subsidiary of Ichnos Glenmark Innovation, for the investigational multispecific antibody ISB 2001.